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Abstract 
 
Brief interventions are effective for problem drinking and reductions are known to occur in 
association with screening and assessment. The present study sought to assess, amongst participants 
(n = 202) in a clinical trial, how much change occurred between baseline assessment and a one-
session brief intervention (S1), and the predictors of early change. The primary focus was on 
changes in Beck Depression Inventory fastscreen scores and alcohol consumption (standard drinks 
per week) prior to random allocation to nine further sessions addressing either depression, alcohol, 
or both problems. There were large and clinically significant reductions between baseline and S1, 
with the strongest predictors being baseline scores in the relevant domain and change in the other 
domain. Client engagement was also predictive of early depression changes. Monitoring progress in 
both domains from first contact, and provision of empathic care, followed by brief intervention 
appear to be useful for this high prevalence comorbidity. 
 
Keywords: Depression, Alcohol dependence, Comorbidity, Brief intervention, Screening, 
Assessment 
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1. Introduction 
 Alcohol use disorders and major depression frequently co-occur in the community 
(Degenhardt, Hall, & Lynskey, 2001; Farrell et al., 2001; Grant et al., 2004; Kessler et al., 2003; 
Teesson, Slade, & Mills, 2009). Of individuals with a 12-month alcohol use disorder, 18% have a 
coexisting affective disorder and 17% of those with an affective disorder have an alcohol use 
disorder (Burns & Teesson, 2002). These comorbidities are even more common in clinical settings 
ranging from 50% to 70% for depression and alcohol use disorders (Flynn & Brown, 2008; Rush & 
Koegl, 2008; Weaver et al., 2003). This high-prevalence comorbidity is associated with poorer 
outcomes and greater utilisation of services when accessed (Sullivan, Fiellin, & O'Connor, 2005), 
however, treatment for these comorbid conditions is often considered more complicated and 
difficult, and hence is often not provided (Roeloffs, Fink, Unutzer, Tang, & Wells, 2001). 
  Whilst much is known about the epidemiology and characteristics of people with comorbid 
alcohol use and depressive disorders, comparatively little is known about the effectiveness of 
treatment for this comorbidity. Experts have called for urgent attention to be paid to this issue, 
particularly on improving the screening and treatment options for primary care practitioners, who 
are often responsible for the management of people experiencing these conditions. In the alcohol 
field, brief interventions have been shown to be effective for problem drinking (e.g., Moyer, Finney, 
Swearingen, & Vergun, 2002; Vasilaki, Hosier, & Cox, 2006), but this approach to treatment has 
only recently been applied to people with comorbid depression and alcohol use problems. A 
randomised controlled trial (Baker et al., 2010) was conducted among a sample of 284 people with 
coexisting depression and alcohol use problems in Australia, comparing several variants of a ten-
session treatment program with a one-session brief intervention. In this study, significant change 
occurred across all treatment conditions, including the brief intervention group, in both problem 
drinking and coexisting depression. This phenomenon has also been observed in research applying 
brief interventions to problem drinkers (e.g., Bernstein, Bernstein, & Heeren, 2010; Jenkins, 
McAlaney, & McCambridge, 2009), suggesting that minimal interventions incorporating an 
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assessment and brief intervention may be as effective as more intensive approaches in targeting 
depression and alcohol misuse comorbidity. 
 Other factors, such as gender (Moyer et al., 2002; Sanchez-Craig, Spivak, & Davila, 1991), 
readiness to change (Prochaska & DiClemente, 1983) and initial therapeutic alliance (Kay-
Lambkin, Baker, Lewin, & Carr, 2011a) may moderate the impact of brief interventions, or 
otherwise alter the initiation or rate of improvement. In addition to formal brief interventions, 
volunteering for treatment, participating in assessments, and the general motivational effect of 
answering questions about their problems may have an impact (Bernstein et al., 2010). Thus, 
changes in behaviour, symptoms and functioning may begin to occur relatively early and we need to 
better understand these processes and the factors that contribute to them. More broadly, attention 
also needs to be paid to inter-relationships between changes in depressive symptoms and alcohol 
consumption. Reciprocal relationships have been demonstrated, for example, between changes in 
negative affect (depression and anger expression) and alcohol use during the first post-treatment 
year in large samples with alcohol use disorders (Witkiewitz & Villarroel, 2009). 
The study conducted by Baker et al. (2010) included both initial screening and extensive 
assessment before the brief intervention began. The opportunity therefore arose to measure changes 
in depressive symptoms and alcohol consumption over this initial period. Hence, in the current 
analyses, drawn from the same study, we sought to determine: (i) how much change occurred 
between screening or baseline and an initial intervention session (S1); (ii) whether change occurred 
in both drinking and depression during this period; and (iii) the predictors of change between 
baseline and S1. In attempting to quantify the magnitude of early change, it is useful to establish a 
reference frame, which, in this instance, was identified as the overall change occurring during the 
treatment phase. Consequently, for participants in the current study who received further 
intervention following the initial session, we additionally sought to compare early changes in 
drinking and depression (i.e. between screening/baseline/S1) with those occurring by mid-treatment 
(session 5, S5) and treatment completion (session 10, S10). 
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 2. Materials and methods 
2.1. Design and hypotheses 
 Ethics approval for this project was obtained from the Hunter New England, the University 
of Newcastle, the University of Queensland and the Queensland University of Technology Ethics 
Committees. The overall clinical trial is also registered with the Australian New Zealand Clinical 
Trials Registry (ANZCTR) – Trial acronym: DAISI (Depression and Alcohol Integrated and Single-
focused Interventions); registration date: 18th January, 2007 (ACTRN12607000057482). 
 As described in more detail by Baker et al. (2010), following telephone screening, potentially 
eligible participants (n = 284) attended for baseline assessment and provided written informed 
consent. All participants were offered a single initial session, after which they were randomized to 
no further treatment (brief intervention only; n = 70) or to nine further sessions focused on 
depression (n = 71), alcohol (n = 68) or alcohol and depression (integrated; n = 75); original power 
calculations were based on projected retention rates of 80 participants per condition. Brief 
assessments of levels of depression and alcohol consumption were conducted by therapists upon 
conclusion of S1 for all participants and at S5 and S10 for those assigned to the ten session 
conditions. Allocations were stratified by gender and receipt of pharmacotherapy. We predicted that 
between baseline assessment and S1: (a) significant decreases in depression and alcohol use would 
be reported; and that (b) self-report assessments completed at the conclusion of S1 would be 
positively associated with baseline level of functioning in each domain, primacy of the relevant 
domain, change in the other domain, therapeutic alliance, and for alcohol consumption, readiness to 
change drinking. As depression scores (not alcohol) were available at screening, the change in 
depressive symptoms between screening and baseline assessment is also reported. 
 
 5
2.2. Participants 
 Inclusion criteria were: (i) aged over 16 years; (ii) a BDI-II (Beck, Steer, & Garbin, 1988) full 
score  17; and (iii) hazardous alcohol consumption in the month before baseline ( an average of 
four 10g ethanol drinks per day for men,  two per day for women) (Baker et al., 2010). Potential 
participants were excluded if they: (i) were currently diagnosed with a psychotic disorder; (ii) 
reported a history of traumatic brain injury; (iii) lacked fluency in English; or (iv) lived too far away 
to attend sessions. The study was implemented between October 2005 and April 2007 across two 
east-coast Australian cities (Newcastle and Brisbane). Most participants self-referred, after seeing 
advertisements in local media (76%) or hearing about the study from others (7%), while 14% were 
referred by other agencies; please see Figure 1 in Baker et al. (2010) for overall recruitment and 
retention profiles. Participants attended sessions in research clinics, community mental health, or 
alcohol and other drug centres. As the primary focus of this paper was on early changes (and 
comparisons with the remainder of the treatment phase), the target sample for the current analyses 
comprised study participants who completed S1 and the 18-week post-treatment assessment (n = 
202, or 71.1% of the recruited sample), which included the following treatment group membership: 
brief intervention only (n = 50); depression-focused intervention (n = 55); alcohol-focused 
intervention (n = 44); and integrated intervention (n = 53). 
 
2.3. Measures 
 The Structured Clinical Interview for DSM-IV-TR (SCID; First, Gibbon, Spitzer, & 
Williams, 1995) provided current and lifetime diagnoses of a Major Depressive Episode, Alcohol 
Abuse and Dependence. During screening and periodically throughout the intervention phase, 
depressive symptoms were assessed using the seven-item Beck Depression Inventory-Fast Screen 
(BDI-FS; Beck, Steer, & Brown, 2000). The full 21-item BDI-II was used at baseline and on all 
subsequent assessment occasions, from which a BDI-FS score could also be calculated (Beck et al., 
2000; Beck et al., 1988). The Opiate Treatment Index (OTI; Darke, Hall, Wodak, Heather, & Ward, 
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1992) estimated the average standard drinks per day in the previous month. A 2-week Time Line 
Follow Back (TLFB; Sobell & Sobell, 1992) procedure was used to measure the mean number of 
standard (10g ethanol) drinks per week. The Alcohol Use Disorders Identification Test (AUDIT; 
Saunders, Aasland, Babor, de le Fuente, & Grant, 1993) provided a measure of severity of alcohol 
problems during the six months prior to baseline. The Readiness to Change Questionnaire 
(Rollnick, Heather, Gold, & Hall, 1992) was employed to yield scores on pre-contemplation, 
contemplation and action regarding readiness to change problematic drinking. Scores are totalled 
for the items particular to each subsection, and the subsection with the highest total score is the 
baseline stage of change. Therapist opinion on whether depression or alcohol problems were 
primary or secondary (based on a review of the status of each problem over time) was also recorded 
at baseline. Additional measures at baseline (e.g., neurocognitive assessments) and 18 weeks are 
reported elsewhere (Baker et al., 2010; Hunt, Baker, Michie, & Kavanagh, 2009). The Agnew-
Davies Relationship Measure (ARM; Agnew-Davies, Stiles, Hardy, Barkham, & Shapiro, 1998) 
was used to measure therapeutic alliance. It contains 28 self-report items regarding client- and 
therapist-based domains and impressions of the client-therapist relationship. Each item is rated 
according to a 7-point Likert scale, with higher scores indicating more positive perceptions. Five 
subscales are derived, namely bond, partnership, confidence, client initiative and openness. The 
client engagement measure in analyses below is derived from ratings of bond, partnership, 
confidence, and openness, while client initiative was used separately; this decision was guided by 
factor analyses of ARM’s scores from the current and previous studies (Baker et al., 2010; Kay-
Lambkin et al., 2011a; Kay-Lambkin, Baker, Kelly, & Lewin, 2011b). The ARM has been used in 
several trials of CBT for depression (Agnew-Davies et al., 1998). Participants completed the ARM 
after S1 (following randomisation, all participants), and, where assigned to 10-session treatments, 
after S5 and S10 immediately following the session, and returned completed forms to the clinic 
receptionist in a sealed envelope. 
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2.4. Interventions 
 The treatment manual (Kay-Lambkin, Baker, & Bucci, 2005) was adapted from that 
evaluated in the study by Kay-Lambkin et al. (Kay-Lambkin, Baker, & Bucci, 2002; Kay-Lambkin 
et al., 2005) and the interventions have previously been described (Baker et al., 2010). S1, received 
by all participants, comprised assessment feedback, case formulation (covering the development 
and maintenance of coexisting depression and alcohol problems), motivational interviewing (MI), 
planning for behaviour change, and education about depression and hazardous alcohol use. Where 
nine weekly one-hour sessions followed, therapy consisted of MI and cognitive behaviour therapy 
(CBT), including a range of mindfulness components. Integrated sessions addressed the way in 
which depression and alcohol use impacted on each other as well as addressing the two conditions 
in parallel. Baseline assessment and therapy were conducted by therapists who worked across the 
four intervention conditions. 
 
2.5. Procedures 
 Following informed consent, baseline assessments were typically completed over two 1.5 
hour sessions a week apart, and reimbursement of up to $20AUD was given for travel and other 
costs (but not for treatment sessions). Randomisations were generated at the beginning of the study 
and linked to a unique identification code. Allocations were concealed (from therapists and 
participants) in individual sealed envelopes, which were opened by participants at the end of S1, 
ensuring that the content and experience of the initial session would be unaffected by knowledge of 
the allocation. Randomisation was stratified by study site, gender, and presence of concurrent 
antidepressant or anti-craving medication. Of relevance to the current study, post-baseline 
assessments were conducted by the participant’s treating psychologist at the conclusion of S1 (post-
allocation), S5 and S10. Blind follow-up assessment occurred at 18 weeks post-baseline, 
irrespective of treatment completion. For the current analyses, 18-week assessment results were 
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only used in the imputation of missing assessment data from the treatment phase and are not 
reported as separate outcomes. 
 
2.6. Statistics 
 While the primary focus of the statistical analyses was on early change (i.e., from screening 
to the conclusion of S1), these effects need to be contextualised against the overall changes 
occurring during the active treatment phase; consequently, S10 was chosen as the key reference 
point, against which to estimate proportionate early change. To manage missing data for 
participants allocated to the extended therapy conditions, multiple imputation techniques were used, 
in which missing S5 and S10 data were imputed based on age, gender and all available data for the 
relevant domain (i.e., BDI-FS depression or TLFB alcohol consumption) from screening/baseline to 
the 18-week follow-up assessment; 75 S5 scores (26%) and 136 S10 scores (48%) were imputed in 
this manner. Change in each domain was then calculated as the difference between the selected time 
points (using actual or imputed scores). The proportionate change was calculated as the change 
occurring in each adjacent time period divided by the estimated total change by S10. 
 Analyses were performed using STATA (Release 10.1 College Station; Stata Corporation, 
TX, USA), SAS (Version 9.1; SAS Institute Inc., NC, USA), and SPSS (Version 17.0; SPSS, 
Chicago, IL, USA). Descriptive statistics characterised the cohort at baseline. Chi-square analyses 
were used to compare baseline differences for the categorical variables, while one-way analyses of 
variance (ANOVAs) were used for the continuous variables. Paired sample t-tests were used to 
measure the change between selected time points for BDI-FS depression and TLFB alcohol 
consumption. Separate multiple linear regressions were conducted to explore predictors of S1 
depression and alcohol consumption scores, with simultaneous entry of the predictors. To partially 
account for multiple testing, the significance level was set at p<0.01. 
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3. Results 
 Detailed descriptions of the overall sample at baseline (n = 284) have been reported 
elsewhere, along with the short-term (6-month) impact of the interventions on key symptoms 
(Baker et al., 2010). Only selected results that are relevant to the current paper are repeated here. 
 
3.1. Baseline characteristics (n = 202) 
 Socio-demographic and clinical characteristics of the selected sample are summarised in 
Table 1. On average, participants were aged 46.3 years, with an approximately equal split for 
gender and current antidepressant medication status; typically, those taking antidepressants had 
done so for 2 years (104.4 weeks, SD 126.5). For the majority of participants (82.4%), alcohol 
related problems were viewed as primary, with approximately one-quarter (27.2%) at the action 
stage of change. No significant differences existed between treatment groups on the variables of 
interest at baseline. 
Table 1 about here 
3.2. Treatment attendance and retention 
 As reported by Baker et al. (2010), on average, participants offered ten sessions (n = 214) 
attended 5.76 (SD 4.07) sessions, with no significant differences in attendance between the 
treatment groups. The corresponding value for the selected sample (n = 152) was 7.27 (SD 3.56) 
sessions, of whom, 81 (53%) attended all ten sessions; in addition, there were 50 S1 participants 
who were not allocated to one of the more intensive interventions. Likewise, there were comparable 
rates of retention in the current analyses across the treatment groups (ranging from 64.7% to 
77.5%). However, relative to the 202 participants in the selected sample, the remaining 82 
participants (who did not complete S1 and the 18-week post-treatment assessment) tended to report 
higher TLFB mean drinks per week at baseline [57.3 (SD 33.8) vs. 70.7 (SD 58.6), F(1, 282) = 5.84, p 
= 0.016] and to be less likely to be at the action stage of change for alcohol [27.2% vs. 13.4%, Ȥ2(1) = 
6.24, p = 0.013]. 
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 3.3. Change from screening and baseline to intervention session one (S1) 
 The average interval between the initial baseline assessment and S1 was 31.5 days (SD 20.4, 
range: 7-149 days); within that period, the second baseline assessment typically occurred within 
12.0 days (SD 10.6) of the first assessment. For 44 participants, there was an overlap in the 
assessment periods, in that the 2-week TLFB completed at S1 partially covered the timeframe for 
the initial baseline assessment; however, for 30 of these 44 participants, this represented only one 
day of overlap. Therefore, measurement issues are less of a concern than the fact that this subgroup 
had less time within which they could potentially manifest change. 
For the selected sample, a statistically significant reduction occurred in depression, with 
BDI-FS scores reducing from a mean of 11.9 (SD 3.13) at screening to 10.4 (SD 3.44) at baseline. 
This accounted for 18.2% of the overall change in depression by S10 (paired-t = 7.47, df = 179, 
p<0.001, 99% CI of the early change 0.96-1.98), which further reduced to a mean of 8.21 (SD 4.06) 
by the conclusion of S1 (26.4% of overall change by S10; paired-t = 8.48, df = 191, p<0.001, 99% 
CI of the early change 1.47-2.77). The BDI-FS manual suggests that scores of 4-6 are indicative of 
mild depression, 7-9 moderate depression, and 10-21 severe depression (Beck et al., 2000). 
Consequently, at S1 the mean BDI-FS was in the middle of the moderate range; for readers more 
familiar with the full BDI-II, the observed mean change by S1 of 3.59 BDI-FS units equates to 
approximately a 7.80 unit reduction on the full BDI-II. Mean alcoholic drinks per week (as per the 
TLFB) also underwent significant change between baseline and S1, reducing from a mean of 56.5 
(SD 33.8) to a mean of 45.7 (SD 37.7) (35.2% of overall change; paired-t = 4.43, df= 185, p<0.001, 
99% CI of the early change 4.47 – 17.18) during this time period. 
 
3.4. Predictors of S1 BDI-FS depression and TLFB alcohol consumption 
 The left-hand columns of Table 2 display the predictor variables associated with BDI-FS 
depression scores at S1. There were three significant predictors in the multiple linear regression 
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analysis: baseline BDI-FS depression; client engagement; and concurrent change in alcohol 
consumption. Specifically, after adjusting for baseline depression, higher client engagement during 
(and prior to) the initial treatment session predicted lower S1 depression, as did the magnitude of 
the reduction in alcohol consumption from baseline to S1. The right-hand columns of Table 2 report 
similar analyses for S1 alcohol consumption. Once again, there were three significant predictors: 
baseline alcohol consumption; the time interval from initial assessment; and concurrent change in 
BDI-FS depression. Specifically, after adjusting for baseline alcohol consumption, those who took 
longer to return for S1 tended to have higher S1 alcohol consumption, while participants with a 
greater reduction in BDI-FS depression from baseline to S1 also reported lower TLFB mean drinks 
per week at S1. 
Table 2 about here 
 
3.5. BDI-FS and TLFB change profiles across the recruitment and treatment phases 
 Raw and proportionate changes over the selected study phases (e.g., baseline to S1, S1 to 
S5, S5 to S10) for depression and alcohol consumption for each treatment group are displayed in 
Table 3, relative to the estimated overall change by S10. Cumulative overall improvements in 
depression and alcohol scores from screening to session 10 are also illustrated in Figure 1. 
Table 3 and Figure 1 about here 
 As Table 3 shows, with respect to changes in raw BDI-FS depression scores and TLFB 
alcohol consumption scores, there were reductions between all pairs of time points (i.e., all mean 
change scores were negative). Most of these comparisons were statistically significant, with the 
obvious exception of the S5 to S10 changes in the single-focused depression and alcohol 
intervention conditions – which may partially reflect differences in participation rates across 
treatment sessions. As a check on the sensitivity of the results to the data imputation strategies, we 
repeated the S1 to S5, and S5 to S10 comparisons without any data substitution. The findings were 
similar to those in Table 3, with the exception of the S1 to S5 comparison in the single-focused 
 12
alcohol intervention condition, where there was a statistically significant mean reduction of 13.6 
standard drinks (p<0.001) (compared with 11.7 in Table 3, p=0.067). 
Of greater relevance to the current paper are the proportionate changes between baseline and 
S10 displayed in the right-hand columns of Table 3, within each outcome measure. Not 
surprisingly, the largest changes occurred during the most active of the treatment phases, between 
S1 and S5 (e.g., 34.5% of change in depression and 39.7% of change in alcohol use). However, 
there were substantial changes before the first session. For example, the baseline assessment to S1 
changes in BDI-FS depression accounted for 21.5% of the change for the depression condition, 
25.4% for the alcohol condition and 30.4% for the integrated condition. The corresponding 
proportions for TLFB alcohol consumption were: 31.4% for the depression condition, 32.9% for the 
alcohol condition and 37.0% for the integrated condition. 
While the overall and proportional change relative to session 10 cannot be calculated for the 
brief (one session) condition, the early changes which occurred in both BDI-FS depression and 
TLFB alcohol consumption were statistically significant (see Table 3), and generally comparable to 
those reported by participants at similar intervention phases in the extended treatment conditions. 
Moreover, as shown in Table 2, pharmacotherapy status was not associated with BDI-FS or TLFB 
scores at S1, although changes in the opposite domain were predictive. 
 
4. Discussion 
4.1. Identification of early changes 
 To our knowledge, this is the first study to demonstrate improvement in both levels of 
depression and alcohol consumption in association with the screening and assessment process prior 
to extended intervention for this common comorbidity. There were large and clinically significant 
reductions across the four intervention conditions in depression (ranging from 21.5% to 30.4%) and 
alcohol consumption (ranging from 31.4% to 37.0%) between baseline assessment and S1. There 
was also a substantial reduction in depressive symptoms between screening and baseline (ranging 
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from 15.7% to 22.7%). Reductions occurred for the entire sample, irrespective of the primacy of 
either alcohol or depression (see Table 2), suggesting that change from baseline may not be 
contingent on addressing primacy. This is an important finding, which may help to reduce the 
complexity and improve the efficiency of management of patients presenting to primary care with 
this comorbidity. 
It is well recognised that reductions in alcohol consumption occur in association with 
screening and assessment (e.g., Bernstein et al., 2010; Jenkins et al., 2009; Kypri, Langley, 
Saunders, & Cashell-Smith, 2007), however, this has not previously been demonstrated with a 
comorbid sample with depression and hazardous alcohol use. Several hypotheses have been 
proposed to account for this phenomenon, including social desirability bias, regression to the mean 
(Finney, 2008), and screening or assessment reactivity (Bernstein et al., 2010). It seems likely that 
the process of entering treatment, including the decision making involved in contacting the 
researchers, undergoing screening, entering the study and participating in assessment was 
associated with the change reported. From a clinical perspective, identifying the most active 
components of this process would be of great interest. 
The strongest predictors of BDI-FS depression and TLFB alcohol consumption scores at S1 
were baseline scores in the relevant domain (i.e., depression or alcohol consumption) and change in 
the other domain; the latter finding reinforces research by Witkiewitz and Villarroel (2009) about 
the dynamic relationship between changes in negative affect and alcohol use. These influences may 
be direct (e.g., less drinking in association with fewer low mood episodes) or indirect (e.g., 
improving self-efficacy, or by generalisation of change strategies across domains). Qualitative 
studies investigating the process of change would be of interest. The finding that client engagement 
was predictive of lower depression scores at S1 indicates that therapeutic alliance is important 
during the assessment process and in the early phase of intervention. In the present study, the same 
therapists conducted baseline assessments and S1, so engagement was likely to have been built in 
this process, as would be the case in clinical settings. Thus, a relatively simple inquiry about levels 
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of depression and levels of alcohol use, coupled with feedback, a warm engaging approach, and 
initial goal setting may be sufficient to produce significant early change in both depressive and 
alcohol use domains. 
There was a tendency (p = 0.021) for superior reductions in alcohol consumption at S1 to be 
associated with being female. It is possible that this difference partially reflects gender differences 
in overall consumption. Differential social desirability or other reporting biases might also need to 
be considered, with women possibly wishing to be seen as treatment responsive. On the other hand, 
a higher baseline level of drinking for men may have been expected to confer a greater opportunity 
for regression to the mean. Furthermore, Sanchez-Craig (1991) has previously reported that 
problem drinking among women responds well to brief intervention while problem drinking among 
men responds comparatively better to a longer therapist intervention. Moyer et al. (2002) have 
argued that men and women benefit from different sorts of brief interventions. In a primary care 
sample in the USA, Roeloffs et al. (2001) further reported that females with comorbid depression 
and alcohol use problems were less likely to access counselling for their conditions, potentially due 
to the perceived stigma of problematic alcohol/other drug use for women. 
Several of the study’s findings highlight the often reported difficulties associated with 
engaging individuals with substance use problems. For example, the subgroup excluded from the 
current analyses (because of non-completion of S1 and/or the 18-week post-treatment assessment) 
reported higher baseline alcohol consumption and less preparedness to change. Similarly, those who 
returned later for S1 were likely to have been drinking more at that time, suggesting a greater 
reluctance to change (although stage of change was not re-assessed at that point). Being at the 
action stage of change is also likely to reflect an individual’s capacity to change without treatment 
(Prochaska & DiClemente, 1983). Conversely, longer intervals between baseline assessment and S1 
tended to be associated with lower S1 depression scores, suggestive of greater spontaneous recovery 
from depression, ongoing assessment/feedback effects, regression to the mean, or some 
 15
combination of these influences. How best to harness motivation for change during the pre-
treatment phase is worthy of further investigation. 
 
4.2. Limitations 
There are several limitations of this study. Not all participants received two assessment 
sessions, so the effect of the assessment process was variable across the sample. Likewise, the time 
between the initial baseline assessment and S1 was reasonably variable, being less than two weeks 
for 44 subjects, which meant that for this subgroup there was a small overlap in measurement time. 
The latter is unavoidable in a clinical trial in which appointments cannot always be precisely 
scheduled. The assessments of depression and alcohol use at S1, S5 and S10 were initiated by the 
treating clinician (although standardised self-report measures were used), so the potential for 
reporting biases is somewhat higher than at the other assessment time points. While data imputation 
techniques were used (to estimate missing S5 and S10 scores), the key hypotheses related to the 
period up till the end of S1, for which no data substitution occurred. 
Since the initial assessments were conducted by trained clinicians, they may have been 
perceived as ‘therapy sessions’; furthermore, the early changes observed here may not have been as 
strong if trained field staff had conducted the assessment interviews, as opposed to therapists. Client 
engagement was assessed following randomisation after S1, so it is possible that any differences 
between groups could potentially reflect knowledge of intervention allocation and/or impacts 
associated with the brief intervention; however, there were no significant S1 group differences in 
therapeutic alliance (see Table 1). In future studies, alliance might be better measured before 
randomisation. Finally, motivation to change may have been relatively high in the current sample, 
as they could be viewed as predominantly self-referred ‘treatment seekers’; on the other hand, many 
participants had been using antidepressants for a considerable time, presumably with unsatisfactory 
outcomes, so the proportion of treatment resistant cases could have been higher. Receipt of 
pharmacotherapy was not associated with initial improvement (see Table 2), suggesting that the 
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observed assessment/initial intervention effects may be generalisable to other real world treatment 
settings. 
 
4.3. Conclusions 
This study is the first to show that coexisting depression and problem drinking both improve 
during the post-recruitment period as well as during early treatment. The impact of participant 
characteristics (e.g., previous treatment experiences, motivation to change, social desirability 
factors) and the episodic nature of depressive disorders may have also contributed to the early 
changes that were observed. There was an average interval of a month between the initial baseline 
assessment and S1, so there was sufficient time within which some recovery could have occurred, 
whether or not specific assessment or client characteristics played a part. 
Difficulties have been reported in primary care settings in detecting and treating problematic 
alcohol use, with these disorders being less likely to be identified if patients are depressed (Roeloffs 
et al., 2001). Consequently, the current findings also have implications for primary and other health 
care professionals, in that it appears that the ‘generalist’ clinical skills involved in the process of 
referral, screening, and assessment/feedback are helpful for depression and problem drinking. We 
estimate that the typical Australian General Practitioner sees approximately two patients every day 
with similar comorbidity profiles to those targeted here – so, opportunities to initiate appropriate 
brief interventions (or referrals) are high. Although the assessments and intervention sessions 
conducted in this study were longer than would be provided in a primary care setting, it is also 
possible that practitioners working in these settings could schedule more appointments over time 
than was allowable in the present study. Thus, it is recommended that primary care and other health 
professions are encouraged to routinely screen and assess depressive symptoms and alcohol 
consumption in their patients, with the knowledge that this process, coupled with empathic care, 
followed by a brief intervention session, is potentially beneficial in reducing comorbid depression 
and alcohol problems. 
 17
 Acknowledgments 
 
 The authors wish to acknowledge the involvement of the study participants, without whom 
this research would not be possible. Thanks also to Sally Hunt and Jennifer Connolly who 
coordinated the study sites and to the research staff who conducted the therapy and interviews. This 
study was funded by the National Health and Medical Research Council (NHMRC) of Australia 
(ID351115). A NHMRC Senior Research Fellowship supported Professor Amanda Baker and a 
NHMRC Career Development Award supported Dr. Frances Kay-Lambkin. 
 
 
 18
References 
 
Agnew-Davies, R., Stiles, W. B., Hardy, G. E., Barkham, M., & Shapiro, D. A. (1998). Alliance 
structure assessed by the Agnew Relationship Measure (ARM). British Journal of Clinical 
Psychology, 37, 155-172. 
Baker, A., Kavanagh, D., Kay-Lambkin, F., Hunt, S., Lewin, T. J., Carr, V., et al. (2010). Randomised 
controlled trial of CBT for co-existing depression and alcohol problems: Short-term outcome. 
Addiction, 105, 87-99. 
Beck, A. T., Steer, R. A., & Brown, G. K. (2000). BDI-Fast Screen for medical patients: Manual. San 
Antonio, TX: Psychological Corporation. 
Beck, A. T., Steer, R. A., & Garbin, M. G. (1988). Beck Depression Inventory: Second edition manual. 
Orlando: Harcourt Brace and Company. 
Bernstein, J. A., Bernstein, E., & Heeren, T. C. (2010). Mechanisms of change in control group drinking 
in clinical trials of brief alcohol intervention: Implications for bias toward the null. Drug and 
Alcohol Review, 29, 498-507. 
Burns, L., & Teesson, M. (2002). Alcohol use disorders comorbid with anxiety, depression and drug use 
disorders: Findings from the Australian National Survey of Mental Health and Well Being. Drug 
and Alcohol Dependence, 68, 299-307. 
Darke, S., Hall, W., Wodak, A., Heather, N., & Ward, J. (1992). Development and validation of a multi-
dimensional instrument for assessing outcome of treatment among opiate users: The Opiate 
Treatment Index. British Journal of Addiction, 87, 733-742. 
Degenhardt, L., Hall, W., & Lynskey, M. (2001). The relationship between cannabis use, depression and 
anxiety among Australian adults: Findings from the National Survey of Mental Health and Well-
Being. Social Psychiatry and Psychiatric Epidemiology, 36, 219-227. 
Farrell, M., Howes, S., Bebbington, P., Brugha, T., Jenkins, R., Lewis, G., et al. (2001). Nicotine, 
alcohol and drug dependence and psychiatric comorbidity: Results of a national household 
survey. British Journal of Psychiatry, 179, 432-437. 
Finney, J. W. (2008). Regression to the mean in substance use disorder treatment research. Addiction, 
103, 42-52. 
First, M. B., Gibbon, M., Spitzer, R. L., & Williams, J. B. W. (1995). Structured Clinical Interview for 
DSM-IV (SCID). New York: New York State Psychiatric Institute. 
Flynn, P. M., & Brown, B. S. (2008). Co-occurring disorders in substance abuse treatment: Issues and 
prospects. Journal of Substance Abuse Treatment, 34, 36-47. 
Grant, B. F., Stinson, F. S., Dawson, D. A., Chou, S. P., Dufour, M. C., Compton, W., et al. (2004). 
Prevalence and co-occurrence of substance use disorders and independent mood and anxiety 
disorders: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. 
Archives of General Psychiatry, 61, 807-816. 
Hunt, S. A., Baker, A. L., Michie, P. T., & Kavanagh, D. J. (2009). Neurocognitive profiles of people 
with comorbid depression and alcohol use: Implications for psychological interventions. 
Addictive Behaviors, 34, 878-886. 
Jenkins, R. J., McAlaney, J., & McCambridge, J. (2009). Change over time in alcohol consumption in 
control groups in brief intervention studies: Systematic review and meta-regression study. Drug 
and Alcohol Dependence, 100, 107-114. 
Kay-Lambkin, F., Baker, A., & Bucci, S. (2002). Treatment manual for the SHADE project (Self-Help 
for Alcohol/other drug use and Depression). Callaghan, NSW, Australia: The University of 
Newcastle. 
Kay-Lambkin, F., Baker, A., & Bucci, S. (2005). Treatment manual for the DAISI Project (Depression 
and Alcohol Integrated and Single focussed Interventions): Alcohol, depression or integrated 
focus. Callaghan, NSW, Australia: The University of Newcastle. 
 19
 20
Kay-Lambkin, F., Baker, A., Lewin, T., & Carr, V. (2011a). Acceptability of a clinician-assisted 
computerized psychological intervention for comorbid mental health and substance use 
problems: Treatment adherence data from a randomized controlled trial. Journal of Medical 
Internet Research, 13, 254-264. 
Kay-Lambkin, F. J., Baker, A. L., Kelly, B., & Lewin, T. J. (2011b). Clinician-assisted computerised 
versus therapist-delivered treatment for depressive and addictive disorders: A randomised 
controlled trial. Medical Journal of Australia, 195, S44-S50. 
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K. R., et al. (2003). The 
epidemiology of Major Depressive Disorder. JAMA, 289, 3095-3105. 
Kypri, K., Langley, J. D., Saunders, J. B., & Cashell-Smith, M. L. (2007). Assessment may conceal 
therapeutic benefit: Findings from a randomized controlled trial for hazardous drinking. 
Addiction, 102, 62-70. 
Moyer, A., Finney, J. W., Swearingen, C. E., & Vergun, P. (2002). Brief interventions for alcohol 
problems: A meta-analytic review of controlled investigations in treatment-seeking and non-
treatment-seeking populations. Addiction, 97, 279-292. 
Prochaska, J. O., & DiClemente, C. C. (1983). Stages and processes of self-change of smoking: Toward 
an integrative model of change. Journal of Consulting & Clinical Psychology, 51, 390-395. 
Roeloffs, C. A., Fink, A., Unutzer, J., Tang, L., & Wells, K. B. (2001). Problematic substance use, 
depressive symptoms, and gender in primary care. Psychiatric Services, 52, 1251-1253. 
Rollnick, S., Heather, N., Gold, R., & Hall, W. (1992). Development of a short ‘readiness to change’ 
questionnaire for use in brief, opportunistic interventions among excessive drinkers. British 
Journal of Addiction, 87, 743-754. 
Rush, B., & Koegl, C. J. (2008). Prevalence and profile of people with co-occurring mental and 
substance use disorders within a comprehensive mental health system. Canadian Journal of 
Psychiatry-Revue Canadienne De Psychiatrie, 53, 810-821. 
Sanchez-Craig, M., Spivak, K., & Davila, R. (1991). Superior outcome of females over males after brief 
treatment for the reduction of heavy drinking: Replication and report of therapist effects. British 
Journal of Addiction, 86, 867-876. 
Saunders, J. B., Aasland, O. G., Babor, T. F., de le Fuente, J. R., & Grant, M. (1993). Development of 
the Alcohol Use Disorders Identification Test (AUDIT). WHO collaborative project on early 
detection of persons with harmful alcohol consumption. Addiction, 88, 791-804. 
Sobell, L. C., & Sobell, M. B. (1992). Timeline follow-back: A technique for assessing self-reported 
alcohol consumption. In R. Z. Litten & J. P. Allen (Eds.), Measuring alcohol consumption: 
Psychosocial and biochemical methods. (pp. 41-72). Totowa, NJ: Humana Press. 
Sullivan, L. E., Fiellin, D. A., & O'Connor, P. G. (2005). The prevalence and impact of alcohol 
problems in major depression: A systematic review. American Journal of Medicine, 118, 330-
341. 
Teesson, M., Slade, T., & Mills, K. (2009). Comorbidity in Australia: findings of the 2007 national 
survey of mental health and wellbeing. Australian and New Zealand Journal of Psychiatry, 43, 
606-614. 
Vasilaki, E. I., Hosier, S. G., & Cox, W. M. (2006). The efficacy of motivational interviewing as a brief 
intervention for excessive drinking: A meta-analytic review. Alcohol and Alcoholism, 41, 328-
335. 
Weaver, T., Madden, P., Charles, V., Stimson, G., Renton, A., Tyrer, P., et al. (2003). Comorbidity of 
substance misuse and mental illness in community mental health and substance misuse services. 
British Journal of Psychiatry, 183, 304-313. 
Witkiewitz, K., & Villarroel, N. A. (2009). Dynamic association between negative affect and alcohol 
lapses following alcohol treatment. Journal of Consulting and Clinical Psychology, 77, 633-644. 
 
 
Table 1 
Baseline characteristics by intervention condition (for participants who completed S1 and the 18-week assessment, n=202) 
 Intervention condition 
Variable Statistic or category 
Brief 
(n=50) 
Depression
(n=55) 
Alcohol 
(n=44) 
Integrated 
(n=53) 
Total 
(n=202) p-value 
Age (years) Mean (SD) 45.0 (9.9) 46.5 (10.3) 47.3 (11.2) 46.7 (11.0) 46.3 (10.5) 0.738 
Gender Female 23 (46.0%) 26 (47.3%) 23 (52.3%) 23 (43.4%) 95 (47.0%) 0.852 
Single 12 (24.0%) 14 (25.5%) 10 (22.7%) 14 (26.4%) 50 (24.8%) 0.378 
Married/de facto 20 (40.0%) 12 (21.8%) 16 (36.4%) 21 (39.6%) 69 (34.2%)  
Marital status 
Separated/divorced/widowed 18 (36.0%) 29 (52.7%) 18 (40.9%) 18 (34.0%) 83 (41.1%)  
Living arrangements With another adult 27 (54.0%) 32 (58.2%) 25 (56.8%) 34 (64.2%) 118 (58.4%) 0.761 
Current antidepressant medication Yes 23 (46.9%) 31 (56.4%) 28 (63.6%) 28 (52.8%) 110 (54.7%) 0.433 
Primary problem (according to therapist) Alcohol 40 (80.0%) 39 (72.2%) 38 (88.4%) 47 (90.4%) 164 (82.4%) 0.060 
Readiness to change (alcohol) Yes (Action stage) 15 (30.0%) 16 (29.1%) 12 (27.3%) 12 (22.6%) 55 (27.2%) 0.837 
Depression (BDI-FS score) Mean (SD) 9.5 (3.3) 10.8 (3.6) 10.7 (3.5) 10.4 (3.1) 10.3 (3.4) 0.233 
Standard drinks (mean per week) Mean (SD) 55.6 (36.3) 58.3 (32.9) 53.5 (32.7) 61.2 (33.6) 57.3 (33.8) 0.703 
Days from B (initial assessment) to S1 Mean (SD) 28.9 (18.8) 31.2 (17.1) 31.4 (19.3) 34.4 (25.4) 31.5 (20.4) 0.594 
Client engagement (z-score S1 ARMS) Mean (SD) -0.17 (0.96) -0.06 (0.79) -0.03 (0.81) 0.22 (0.63) -0.01 (0.81) 0.099 
Client initiative (z score S1 ARMS) Mean (SD) 0.02 (0.99) 0.10 (1.08) -0.07 (1.04) 0.09 (1.02) 0.04 (1.03) 0.846 
 
BDI-FS: Beck Depression Inventory - Fastscreen score; B: Baseline; S1: session 1; ARMS: Agnew Relationship Measure Scale; p-values are from one-way ANOVAs or 
overall chi-square tests.
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Table 2 
Predictors of depression (BDI-FS) scores and alcohol scores assessed at Session 1 
Outcome:
Depression (BDI-FS) scores 
at Session 1 (S1) 
Standard drinks (mean per week) 
at Session 1 (S1) 
  (R2 = 0.480, n=183) (R2 = 0.479, n=183) 
Predictor Standardised regression weight p-value 
Standardised 
regression weight p-value 
Socio-demographic and baseline measures:     
  Age -0.002 0.972 -0.006 0.913 
  Gender   (Male=0, Female=1) 0.090 0.135 -0.139 0.021 
  Living arrangements   (With another adult=0, Alone or with kids=1) -0.027 0.638 0.088 0.122 
  Current antidepressant medication   (No=0, Yes=1) 0.089 0.127 -0.087 0.133 
  Primary problem (according to therapist)   (Alcohol=0, Depression=1) 0.034 0.557 0.015 0.799 
  Readiness to change (alcohol)   (Yes=0, No=1) 0.042 0.468 0.085 0.138 
  Depression (BDI-FS) – baseline score 0.646 <0.001 -0.102 0.099 
  Standard drinks (mean per week) – baseline score 0.148 0.029 0.514 <0.001 
S1 and change measures:     
  Days from B (initial assessment) to S1 -0.108 0.070 0.159 0.007 
  Client engagement   (z-score S1 ARMS) -0.158 0.008 0.006 0.918 
  Client initiative   (z score S1 ARMS) -0.129 0.025 0.020 0.735 
  Change in other outcome (Standard drinks or BDI-FS) (S1 minus B) 0.291 <0.001 0.266 <0.001 
 
B: Baseline; S1: Session 1; BDI-FS: Beck Depression Inventory Fastscreen score; ARMS: Agnew Relationship Measure Scale; p-values are from multiple linear regression 
analyses. Participants with missing scores for any of the predictors were excluded from these analyses. 
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Table 3 
Changes in depression (BDI-FS) scores and alcohol scores between sessions: overall and separately for each intervention condition 
 
Depression (BDI-FS) scores Standard drinks (mean per week) Intervention condition 
(n for BDI-FS, n for 
Standard drinks) 
Period Change during 
period 
p-value 
Proportion of 
estimated overall 
change by S10 
Change 
during 
period 
p-value 
Proportion of 
estimated overall 
change by S10 
Sc to B -1.65 <0.001 -    Brief (one) session 
(n=48, 46) B to S1 -2.27 <0.001 - -12.34 0.013 - 
        
Sc to B -1.14 0.006 15.7%    
B to S1 -1.56 0.002 21.5% -8.2 0.182 31.4% 
S1 to S5 -3.02 0.001 41.5% -11.1 0.004 42.5% 
Depression (n=52, 50) 
S5 to S10 -1.55 0.158 21.3% -6.8 0.128 26.1% 
        
Sc to B -1.83 <0.001 22.7%    
B to S1 -2.05 <0.001 25.4% -9.1 0.030 32.9% 
S1 to S5 -2.50 <0.001 31.0% -11.7 0.067 42.2% 
Alcohol (n=41, 41) 
S5 to S10 -1.68 0.043 20.8% -6.9 0.242 24.9% 
        
Sc to B -1.39 0.001 16.2%    
B to S1 -2.61 <0.001 30.4% -13.5 0.002 37.0% 
S1 to S5 -2.75 <0.001 32.1% -13.8 0.006 37.8% 
Integrated (n=51, 49) 
S5 to S10 -1.83 0.008 21.3% -9.2 0.007 25.2% 
        
Sc to B -1.47 <0.001 18.2%    
B to S1 -2.12 <0.001 26.4% -10.8 <0.001 35.2% 
S1 to S5 -2.77 <0.001 34.5% -12.2 0.002 39.7% 
Total (n=192, 186) 
S5 to S10 -1.69 0.005 21.0% -7.7 0.022 25.1% 
Sc: Screening; B: Baseline; S1, S5 and S10: Sessions 1, 5 and 10, respectively.
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Fig. 1.  Cumulative improvement in depression scores (BDI-FS, n=192) and alcohol scores (n=186) from screening to session 10 
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